Galway Biomedical
Series A in 2025
Galway Biomedical specializes in the development and manufacturing of medical devices, focusing primarily on surgical implants. Their product portfolio spans various clinical fields, including vascular, dental, orthopaedic, urology, and general surgery, contributing to advancements in biomaterial-based medical device implants.
Ovagen is a biotechnology company specializing in the commercial production of germ-free chicken eggs and birds. Primarily serving the pharmaceutical industry, Ovagen offers contract research services and expertise in specific poultry and rodent research technologies to Good Manufacturing Practice (GMP) standards.
Peroptyx
Seed Round in 2024
Peroptyx is a company that specializes in providing location-based machine learning training data and model evaluation solutions for global technology brands. Its platform is designed to deliver high-quality training data and ensure accurate model evaluation through the integration of personalized authentication, onboarding, and performance analytics. By leveraging unique innovations in data security, geo-location, and identity, Peroptyx aims to minimize bias and errors in machine learning training data. This enables product and data science leaders to obtain high-fidelity, locally relevant data essential for training algorithms across various applications, including maps, search, music, voice, and generative artificial intelligence services. Peroptyx's solutions are tailored to meet the needs of consumer-facing organizations, allowing them to deploy reliable models more efficiently.
CitySwift
Venture Round in 2024
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, CitySwift utilizes artificial intelligence and machine learning to predict journey times and passenger demand, enhancing route efficiency. The company's platform analyzes historical patterns to understand the impact of factors such as weather, traffic, and events on routes, cycle times, and patronage. This enables schedulers to create optimized timetables that ensure on-time performance and increased passenger satisfaction while helping bus operators improve network efficiency.
FeelTect
Venture Round in 2023
FeelTect is a medical device company based in Galway, Ireland, founded in 2019, that develops and markets pressure sensing devices for compression therapy of venous leg ulcers. Its device measures and monitors sub-bandage pressure, enabling live readings and recorded data to support safe, effective, individualized treatment during and outside clinical settings, with the aim of ensuring correct compression levels and reducing healthcare burden.
Amara Therapeutics
Seed Round in 2023
Amara Therapeutics specializes in empowering individuals to manage their pelvic health through its digital therapeutic platform. The company offers safe, non-invasive care pathways supported by evidence-based medicine and behavioral interventions.
Bluedrop Medical
Venture Round in 2023
Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.
ByoWave
Seed Round in 2023
ByoWave is a company that specializes in creating inclusive gaming experiences through its innovative video game controller, the Proteus Controller. This modular controller is designed to accommodate both disabled and non-disabled gamers, featuring a unique 'snap and play' system that allows users to easily connect various components. ByoWave's approach enables gamers to customize their controller configurations online, facilitating sharing and collaboration within the gaming community. The Proteus Controller is compatible with popular gaming platforms, including Xbox and PC, ensuring a versatile solution for a diverse audience.
Ovagen
Venture Round in 2023
Ovagen is a biotechnology company specializing in the commercial production of germ-free chicken eggs and birds. Primarily serving the pharmaceutical industry, Ovagen offers contract research services and expertise in specific poultry and rodent research technologies to Good Manufacturing Practice (GMP) standards.
CitySwift
Series A in 2022
CitySwift is a technology company based in Galway, Ireland, specializing in data-driven scheduling and planning for urban bus networks. Founded in 2016 by Alan Farrelly and Brian O'Rourke, CitySwift utilizes artificial intelligence and machine learning to predict journey times and passenger demand, enhancing route efficiency. The company's platform analyzes historical patterns to understand the impact of factors such as weather, traffic, and events on routes, cycle times, and patronage. This enables schedulers to create optimized timetables that ensure on-time performance and increased passenger satisfaction while helping bus operators improve network efficiency.
Signum Surgical
Venture Round in 2022
Signum Surgical is a medtech company developing bio-absorbable implant devices to treat colorectal diseases, with a focus on perianal fistulas. Founded in 2014 by Eoin Bambury and Moshe Zilversmit and based in Galway, Ireland, the company aims to prevent reinfection and accelerate healing after fistula surgery. Its devices securely close the fistula tract and dissolve within the body after treatment, enabling long-lasting healing.
3D Issue
Venture Round in 2022
3D Issue operates a content creation platform designed to transform PDFs into responsive, interactive digital publications suitable for various devices. Its solution centralizes content for multi-screen distribution, enhances sharing functionality, and improves publication conversion.
Hooke Bio
Seed Round in 2022
Hooke Bio Ltd. is a biotechnology company based in Shannon, Ireland, focused on developing microfluidic technologies for drug screening and related applications. Founded in 2014, the company has created a fully integrated high-throughput screening system that utilizes 3D microtissues, such as spheroids and organoids, to generate biological data. This innovative, patent-protected technology aims to reduce reliance on animal models in preclinical studies and accelerate the drug development process. By enabling pharmaceutical companies and clinicians to develop more accurate disease models and optimize treatments based on individual patient samples, Hooke Bio enhances the ability to test and repurpose drugs effectively, ultimately improving patient care and outcomes.
Versono Medical
Venture Round in 2022
Versono Medical is an early stage Irish MedTech company located in Galway, a global centre for excellence in medical technologies. The company collaborates with clinicians and research institutions across the world.
FeelTect
Seed Round in 2022
FeelTect is a medical device company based in Galway, Ireland, founded in 2019, that develops and markets pressure sensing devices for compression therapy of venous leg ulcers. Its device measures and monitors sub-bandage pressure, enabling live readings and recorded data to support safe, effective, individualized treatment during and outside clinical settings, with the aim of ensuring correct compression levels and reducing healthcare burden.
Bluedrop Medical
Venture Round in 2021
Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.
Tympany Medical
Seed Round in 2021
Tympany Medical develops a platform for minimally invasive ear surgeries. Its device enables surgeons to perform complex procedures using sterile endoscopy, reducing unnecessary mastoidectomies and enhancing surgical outcomes.
Content Llama
Seed Round in 2021
Content Llama Limited is a Donegal, Ireland-based company established in 2019 that operates a digital content platform designed to connect brands with retailers, specifically in the online sports, outdoor fashion, and pharmacy sectors. The platform automates the collection, configuration, and delivery of multi-source product content, including descriptions and images, tailored to the specific needs of eCommerce retailers. By utilizing advanced Content Configuration Technology and a dedicated team, Content Llama serves as a digital content gateway, sourcing, organizing, and transforming product information into formats compatible with retailers' internal systems such as PIM, DAM, CMS, and eCommerce platforms. This streamlined approach ensures that retailers receive high-quality, accurate product content, enhancing their online merchandising efforts and ultimately facilitating better customer engagement and sales conversions.
Locker
Pre Seed Round in 2021
Locker is a sports media platform that personalizes content consumption for fans worldwide. It uses machine learning algorithms to aggregate trusted sources, offering users a single app to follow thousands of topics from hundreds of media brands. Currently available in the UK and Ireland, Locker indexes over 1500 sports publications daily.
Palliare is a medical technology company focused on advancing smoke insufflation and evacuation solutions tailored for various surgical applications, including robotic, laparoscopic, endoluminal, and colorectal procedures. The company offers products such as the EVA15 insufflator and a specialized smoke evacuation system, designed to enhance surgical workflows while safeguarding operating room staff from the dangers of surgical smoke and aerosolized viruses. Palliare aims to establish itself as a leader in the field of advanced insufflation technology, addressing the needs of minimally invasive surgery and providing hospitals with effective solutions for smoke management during surgical procedures.
Peroptyx
Seed Round in 2021
Peroptyx is a company that specializes in providing location-based machine learning training data and model evaluation solutions for global technology brands. Its platform is designed to deliver high-quality training data and ensure accurate model evaluation through the integration of personalized authentication, onboarding, and performance analytics. By leveraging unique innovations in data security, geo-location, and identity, Peroptyx aims to minimize bias and errors in machine learning training data. This enables product and data science leaders to obtain high-fidelity, locally relevant data essential for training algorithms across various applications, including maps, search, music, voice, and generative artificial intelligence services. Peroptyx's solutions are tailored to meet the needs of consumer-facing organizations, allowing them to deploy reliable models more efficiently.
Atlantic Therapeutics Limited
Venture Round in 2021
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.
InVera Medical
Seed Round in 2020
InVera Medical specializes in developing innovative medical devices focused on treating chronic venous disease. Their flagship product, BioVena™, offers a less invasive, pain-free solution for varicose veins and venous ulcers, utilizing the body's natural biological response.
Fincovi
Seed Round in 2020
Fincovi is a technology company that offers specialized software applications and hosted solutions tailored for renewable energy companies. Its cloud-based financial services platform aims to enhance financial management, compliance, and insights, ultimately maximizing the value of energy portfolios. By leveraging advanced technology, Fincovi seeks to reduce operational costs associated with back- and middle-office functions in the renewable energy sector. The platform facilitates improved communication and information flow among stakeholders, enabling developers and fund managers to effectively build, originate, and fundraise for new projects. Through its open and connected ecosystem, Fincovi supports the growth and efficiency of renewable energy initiatives.
Cerebreon
Seed Round in 2020
Cerebreon Technologies Ltd., established in 2016 and based in Portnoo, Ireland, specializes in advanced data analytics, business management systems, and process automation. The company develops software solutions for the insolvency market, using machine learning and smart analytics to predict debt recovery outcomes, enhance efficiency, reduce costs, and ensure compliance. Cerebreon caters to businesses of all sizes and sectors, providing bespoke solutions and expert consultancy services to make high-end analytics accessible and beneficial to a wide range of enterprises.
A community project bridging the disconnect between remote work and local impact in rural area.
AtriAN Medical
Seed Round in 2019
AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.
Bluedrop Medical
Seed Round in 2019
Founded in 2014, Bluedrop Medical develops an IoT-enabled device for early detection of diabetic foot ulcers. Its home-based system scans patients' feet daily, sends data to the cloud for analysis, and alerts healthcare providers to potential abnormalities, reducing amputation risks.
Hooke Bio Ltd. is a biotechnology company based in Shannon, Ireland, focused on developing microfluidic technologies for drug screening and related applications. Founded in 2014, the company has created a fully integrated high-throughput screening system that utilizes 3D microtissues, such as spheroids and organoids, to generate biological data. This innovative, patent-protected technology aims to reduce reliance on animal models in preclinical studies and accelerate the drug development process. By enabling pharmaceutical companies and clinicians to develop more accurate disease models and optimize treatments based on individual patient samples, Hooke Bio enhances the ability to test and repurpose drugs effectively, ultimately improving patient care and outcomes.
Loci Orthopaedics
Seed Round in 2018
Founded in 2017, Loci Orthopaedics specializes in developing innovative medical technologies for orthopedics. The company is renowned for its InDx implant, the only device that fully mimics natural thumb joint motions and offers a less invasive surgical treatment option.
Neurent Medical
Seed Round in 2018
Founded in 2015, Neurent Medical is a medical device company based in Galway, Ireland. It specializes in developing non-surgical treatments for chronic rhinitis using minimally invasive, hand-held radio-frequency devices.
Kite Medical
Seed Round in 2018
Kite Medical, established in 2016 and headquartered in Galway, Ireland, specializes in the manufacture of a non-invasive, wearable device for detecting kidney reflux in children with urinary tract infections. This innovative solution aims to replace complex procedures and hospital visits, benefiting both patients and healthcare providers. The device targets a prevalent condition affecting up to 3% of young children, helping in early detection and preventing potential long-term kidney damage.
Neuravi Limited, established in 2009 and based in Galway, Ireland, specializes in designing and developing medical devices for treating acute ischemic strokes. The company's primary product, the EmboTrap revascularization device, is designed to restore blood flow by removing clots from blocked brain arteries. Neuravi operates in multiple European countries and is a subsidiary of DePuy Ireland Unlimited Company.
Embo Medical
Seed Round in 2014
Embo Medical, located at the National University of Ireland, is focused on developing innovative medical devices for vascular embolization. The company is creating the Caterpillar, a groundbreaking one-shot embolization device designed to enhance the efficiency and safety of peripheral vascular embolization procedures. This device aims to significantly reduce procedural times, enabling physicians to perform embolizations in a more cost-effective manner. With approximately 180,000 such procedures conducted annually worldwide, Embo Medical is positioned to make a meaningful impact in the medical field by improving patient outcomes and streamlining medical practices.
Good4U
Venture Round in 2014
Good4U is a company that specializes in the production and sale of nutritious sprouts and shoots, aimed at enhancing health and well-being. Established in 2004 by Bernie and her daughter Michelle, a certified dietitian and nutritionist, Good4U developed a unique 'Super Sprouts' mix that features a combination of brocco sprouts and super shoots. The company's products are crafted from plant-based ingredients, ensuring they are free from additives and preservatives, and are designed to meet the dietary needs of health-conscious consumers, including athletes. Good4U focuses on providing high-quality, nutritious food options at reasonable prices, making healthy eating accessible to a wider audience.
SyncroPhi Systems
Seed Round in 2013
SyncroPhi Systems Ltd. is a medical device company located in Galway, Ireland, specializing in the development and commercialization of advanced wireless patient-monitoring systems. Founded in 2007, the company aims to enhance healthcare delivery in front-line settings across the European Union. Its flagship product, KEWS300, is a nursing software that provides healthcare professionals with accurate point-of-care information, facilitating real-time patient tracking and support. SyncroPhi Systems operates under an ISO 13485:2003 certified Quality Management System, ensuring that all products are designed and manufactured in compliance with relevant medical device regulations. The company is focused on improving patient care, optimizing patient flow, and enabling hospital research through its innovative solutions.
Kelsius
Venture Round in 2012
Kelsius is a provider of automation technology focused on product safety and compliance for the food services and healthcare sectors. Established in 2003 and headquartered in Donegal, Ireland, the company specializes in wireless temperature monitoring systems and digital HACCP management solutions. Kelsius's technology enhances product safety and ensures adherence to regulatory standards while also optimizing costs related to these processes. By reducing product wastage linked to refrigeration failures and improving food quality, Kelsius empowers its clients to achieve significant cost savings and labor efficiencies through automation.
Marvao Medical
Venture Round in 2011
Marvao Medical Devices, Ltd. is a company focused on the development, manufacturing, and marketing of medical devices aimed at reducing the risk of catheter-related bloodstream infections. The company specializes in creating implantable devices that manage the exit sites of central venous catheters, providing patients with a natural barrier at these critical access points. By addressing the challenges associated with long-term vascular access, Marvao Medical seeks to enhance patient safety and improve health outcomes in individuals requiring extensive catheter use.
FMC-Tech
Funding Round in 2010
FMC-Tech Ltd, established in August 2001, specializes in developing network management systems for medium voltage overhead electricity networks. The company's flagship product, the Crystal System, is designed to enhance network performance and address regulatory requirements. By delivering network intelligence, FMC-Tech aims to improve customer satisfaction while simultaneously reducing operational costs. The system provides a comprehensive solution to meet the evolving demands of the electricity sector, ensuring that businesses can effectively manage their networks in a cost-efficient manner.
Touch Ltd., a software company, provides integrated and unified audio visual and information technology convergence solutions. It offers 3touch ENTERPRISE, a client server based multimedia solution that stores, manages, and controls various presentation and multimedia materials, as well as allows access to and play-out that information; and 3touch Media Editor software, which helps to develop a digital signage playlist. The company also provides 3touch Room Control, a system designed to link to various legacy control solutions and interact with existing or new installs; and 3touch TV network, a video delivery and display system that plays live video either on demand or according to a preset schedule. In addition, it offers 3touch Encoding, which provides various ways to get the live stream on the network; and 3touch Video on Demand Module, a system that streams content through a set-top box, allows viewing in real time, or allows watching it through a software player. Te company’s solutions are used in various audio visual areas, such as presentation and content management and delivery, interactive whiteboard applications, room control, room booking and management system, automated video conferencing scheduling and setup, equipment and personal computer monitoring, and IPTV/ video on demand and digital signage.
3Touch Ltd. was founded in 2003 and is headquartered in Athlone, Ireland with additional offices in Cambridge, the United Kingdom.
Lightstorm Networks
Series A in 2006
Lightstorm Networks designs, develops, and supplies semiconductor solutions. It provides hardware and software subsystems. The company's products include Brooklyn-10 Carrier Ethernet Switch, a layer 2 switch with an integrated 20G traffic manager; Solas Software Suite, a carrier Ethernet software development platform, including APIs, drivers, and development tools; and B-10 Development Platform, a 3RU development system that demonstrates the functionality of the Brooklyn-10 and partner silicon solutions. Its products are used in multiservice provisioning platform, wireless backhaul, document library, and carrier Ethernet switch and router applications.